Wells A. Messersmith

Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from An In vivo Platform for Translational Drug Development in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6518317.v1

Top 100%

0DataRank

Top 100%0 citations

Antonio Jimeno, George Cusatis, Xianfeng Zhang, Christine A. Iacobuzio–Donahue, Collins Karikari +18 more

Papers

Driven by 39 papers — median percentile 0. Top paper: “Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas”.

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1963

N/A

0.889DataRank · unranked

374 citations

Randy F. Sweis, F. Stephen Hodi, Wells A. Messersmith, Robert H.I. Andtbacka, Matthew Ingham +11 more

Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0041

N/A

0.710DataRank · unranked

113 citations

Meryl D. Colton, Siddhartha S. Mitra, Wells A. Messersmith, Robert W. Lentz

Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Cancer Research(2021)10.1158/0008-5472.can-20-3892

N/A

0.637DataRank · unranked

69 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

Nature Computational Science(2024)10.1038/s43588-024-00597-5

N/A

0.617DataRank · unranked

17 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0106

N/A

0.510DataRank · unranked

29 citations

Qiong Zhou, Hector Esquer, Laura A. Pike, Travis P. Broneske, Sébastien Rinaldetti +10 more

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0065

N/A

0.488DataRank · unranked

16 citations

Adrian T.A. Dominguez, Shaikh M. Atif, Alberto Dinarello, Tania Azam, Kibrom M. Alula +11 more

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

Cancers(2020)10.3390/cancers12030719

N/A

0.483DataRank · unranked

24 citations

Dennis M. Simmons, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman +7 more

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers

Frontiers in Oncology(2021)10.3389/fonc.2021.614640

N/A

0.345DataRank · unranked

9 citations

Megan Marsh, Martin D. McCarter, Robert A. Meguid, Narine Wandrey Bhardwaj, John D. Mitchell +17 more

Figure S5 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Figshare(2023)10.1158/0008-5472.24895390.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Supplementary Tables from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Figshare(2023)10.1158/0008-5472.24895378.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S6 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895387

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S4 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Figshare(2023)10.1158/0008-5472.24895393.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S4 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895393

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S1 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895402

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Data from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.c.6994537.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Supplementary Legends from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895384

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02701-w

N/A

0DataRank · unranked

40 citations

Adam C. Mueller, Miles Piper, Dallin Milner, Benjamin Van Court, Shilpa Bhatia +14 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

Frontiers in Immunology(2021)10.3389/fimmu.2021.607282

N/A

0DataRank · unranked

50 citations

Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman +26 more

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology(2021)10.3389/fonc.2021.642328

N/A

0DataRank · unranked

30 citations

Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu +8 more

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models

Frontiers in Oncology(2022)10.3389/fonc.2022.877635

N/A

0DataRank · unranked

16 citations

Alexis D. Leal, Juan A. Marín‐Jiménez, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro +14 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.118

N/A

0DataRank · unranked

8 citations

Patrick J. Blatchford, Robert W. Lentz, S. Lindsey Davis, Sunnie S. Kim, Alexis D. Leal +9 more

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524974

N/A

0DataRank · unranked

2 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps257

N/A

0DataRank · unranked

0 citations

Junxiao Hu, Patrick J. Blatchford, Todd M. Pitts, Alexis D. Leal, Sunnie S. Kim +7 more

Data from An In vivo Platform for Translational Drug Development in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6518317.v1

Top 100%

0DataRank

Top 100%0 citations

Antonio Jimeno, George Cusatis, Xianfeng Zhang, Christine A. Iacobuzio–Donahue, Collins Karikari +18 more

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0090

N/A

0DataRank · unranked

9 citations

Tyler J. Friedrich, Patrick J. Blatchford, Kimberly R. Jordan, Todd M. Pitts, Hannah R. Robinson +13 more

Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)

PLoS ONE(2024)10.1371/journal.pone.0298808

N/A

0DataRank · unranked

8 citations

Betelehem W. Yacob, Monica E. Brown, Brandon R. Goldstein, John J. Arcaroli, Stacey M. Bagby +11 more

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models

International Journal of Molecular Sciences(2024)10.3390/ijms252313160

N/A

0DataRank · unranked

5 citations

Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade, Laura A. Pike +4 more

Results of a phase 2 study of evorpacept (E, ALX148), cetuximab (C), and pembrolizumab (P) in patients with refractory microsatellite stable metastatic colorectal cancer (MSS CRC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.3530

N/A

0DataRank · unranked

1 citations

Patrick J. Blatchford, Junxiao Hu, Todd M. Pitts, Adrie Van Bokhoven, Hannah R. Robinson +13 more

Supplementary Tables from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895378

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

Frontiers in Oncology(2025)10.3389/fonc.2025.1546500

N/A

0DataRank · unranked

0 citations

Sama L. Kareem, Bradley R. Corr, Christopher H. Lieu, Breelyn A. Wilky, S. Lindsey Davis +9 more

Supplementary Methods from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Figshare(2023)10.1158/0008-5472.24895381.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S2 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895399

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S1 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895402.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S3 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895396

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S3 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Figshare(2023)10.1158/0008-5472.24895396.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S5 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

(2023)10.1158/0008-5472.24895390

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Figure S2 from Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Figshare(2023)10.1158/0008-5472.24895399.v1

N/A

0DataRank · unranked

0 citations

Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia +32 more

Wells A. Messersmith

Indexed papers

Top data-sharing exemplar

Papers